FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086062007> ?p ?o ?g. }

• W2086062007 endingPage "245" @default.
• W2086062007 startingPage "239" @default.
• W2086062007 abstract "Postoperative management of patients with pancreatic adenocarcinoma (PA) is controversial.The aim of this pilot study was to assess the feasibility of postoperative combination chemotherapy followed by radiotherapy in patients aged 18-70 years with a histological diagnosis of PA, and Karnofsky performance status (KPS) > or =70. Cisplatin and epirubicin 40 mg/m2 on day 1, gemcitabine 600 mg/m2 on day 1 and 8, and 5-fluorouracil 200 mg/m2/day as protracted infusion (PEFG regimen) were delivered every 28 days for 4 cycles. Assuming a minimum one-year disease-free survival (DFS) of interest of 65% and a maximum of low interest of 45% (alpha 0.05; beta 0.10), the target enrollment was 51 patients, and the strategy would be considered to deserve further analysis if more than 29 patients were DF at one-year from surgery.Fifty-one patients, KPS >80: 29, median tumor size 3.5 cm, stage II/III/IVA: 2/34/13, grade 3-4: 22, positive resection margins: 26, node positive: 46, received 179 cycles of chemotherapy. Main grade 3/4 toxicity consisted of neutropenia (51%), thrombocytopenia (18%), and anemia (4%). One-year DFS was 67 +/- 7%. Two-year overall survival was 53 +/- 7%.Postoperative management of PA with this multimodality strategy was well tolerated and yielded a promising outcome." @default.
• W2086062007 created "2016-06-24" @default.
• W2086062007 creator A5014631551 @default.
• W2086062007 creator A5015936724 @default.
• W2086062007 creator A5022335076 @default.
• W2086062007 creator A5025811482 @default.
• W2086062007 creator A5027838511 @default.
• W2086062007 creator A5029031145 @default.
• W2086062007 creator A5033134171 @default.
• W2086062007 creator A5038760660 @default.
• W2086062007 creator A5039979956 @default.
• W2086062007 creator A5072356061 @default.
• W2086062007 date "2005-01-01" @default.
• W2086062007 modified "2023-10-01" @default.
• W2086062007 title "Final Results of a Prospective Trial of a PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) Regimen Followed by Radiotherapy after Curative Surgery for Pancreatic Adenocarcinoma" @default.
• W2086062007 cites W1931508686 @default.
• W2086062007 cites W1974215313 @default.
• W2086062007 cites W1978264916 @default.
• W2086062007 cites W1979300931 @default.
• W2086062007 cites W1999827103 @default.
• W2086062007 cites W2000424590 @default.
• W2086062007 cites W2002795798 @default.
• W2086062007 cites W2005660567 @default.
• W2086062007 cites W2007711555 @default.
• W2086062007 cites W2047318784 @default.
• W2086062007 cites W2054234815 @default.
• W2086062007 cites W2062828086 @default.
• W2086062007 cites W2066097107 @default.
• W2086062007 cites W2069752133 @default.
• W2086062007 cites W2075244358 @default.
• W2086062007 cites W2082953190 @default.
• W2086062007 cites W2091188319 @default.
• W2086062007 cites W2097684742 @default.
• W2086062007 cites W2099015389 @default.
• W2086062007 cites W2111736523 @default.
• W2086062007 cites W2115812130 @default.
• W2086062007 cites W2128203605 @default.
• W2086062007 cites W2133373388 @default.
• W2086062007 cites W2141387649 @default.
• W2086062007 cites W2144263487 @default.
• W2086062007 cites W2150881991 @default.
• W2086062007 cites W2260154196 @default.
• W2086062007 cites W2313887201 @default.
• W2086062007 cites W2470353582 @default.
• W2086062007 doi "https://doi.org/10.1159/000086780" @default.
• W2086062007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16015040" @default.
• W2086062007 hasPublicationYear "2005" @default.
• W2086062007 type Work @default.
• W2086062007 sameAs 2086062007 @default.
• W2086062007 citedByCount "18" @default.
• W2086062007 countsByYear W20860620072012 @default.
• W2086062007 countsByYear W20860620072017 @default.
• W2086062007 countsByYear W20860620072018 @default.
• W2086062007 crossrefType "journal-article" @default.
• W2086062007 hasAuthorship W2086062007A5014631551 @default.
• W2086062007 hasAuthorship W2086062007A5015936724 @default.
• W2086062007 hasAuthorship W2086062007A5022335076 @default.
• W2086062007 hasAuthorship W2086062007A5025811482 @default.
• W2086062007 hasAuthorship W2086062007A5027838511 @default.
• W2086062007 hasAuthorship W2086062007A5029031145 @default.
• W2086062007 hasAuthorship W2086062007A5033134171 @default.
• W2086062007 hasAuthorship W2086062007A5038760660 @default.
• W2086062007 hasAuthorship W2086062007A5039979956 @default.
• W2086062007 hasAuthorship W2086062007A5072356061 @default.
• W2086062007 hasConcept C121608353 @default.
• W2086062007 hasConcept C126322002 @default.
• W2086062007 hasConcept C141071460 @default.
• W2086062007 hasConcept C2776694085 @default.
• W2086062007 hasConcept C2776755627 @default.
• W2086062007 hasConcept C2777063308 @default.
• W2086062007 hasConcept C2778239845 @default.
• W2086062007 hasConcept C2778248108 @default.
• W2086062007 hasConcept C2778424827 @default.
• W2086062007 hasConcept C2780258809 @default.
• W2086062007 hasConcept C2780456651 @default.
• W2086062007 hasConcept C2780835546 @default.
• W2086062007 hasConcept C2781182431 @default.
• W2086062007 hasConcept C2781413609 @default.
• W2086062007 hasConcept C509974204 @default.
• W2086062007 hasConcept C71924100 @default.
• W2086062007 hasConcept C90924648 @default.
• W2086062007 hasConceptScore W2086062007C121608353 @default.
• W2086062007 hasConceptScore W2086062007C126322002 @default.
• W2086062007 hasConceptScore W2086062007C141071460 @default.
• W2086062007 hasConceptScore W2086062007C2776694085 @default.
• W2086062007 hasConceptScore W2086062007C2776755627 @default.
• W2086062007 hasConceptScore W2086062007C2777063308 @default.
• W2086062007 hasConceptScore W2086062007C2778239845 @default.
• W2086062007 hasConceptScore W2086062007C2778248108 @default.
• W2086062007 hasConceptScore W2086062007C2778424827 @default.
• W2086062007 hasConceptScore W2086062007C2780258809 @default.
• W2086062007 hasConceptScore W2086062007C2780456651 @default.
• W2086062007 hasConceptScore W2086062007C2780835546 @default.
• W2086062007 hasConceptScore W2086062007C2781182431 @default.
• W2086062007 hasConceptScore W2086062007C2781413609 @default.
• W2086062007 hasConceptScore W2086062007C509974204 @default.
• W2086062007 hasConceptScore W2086062007C71924100 @default.
• W2086062007 hasConceptScore W2086062007C90924648 @default.

• next